相关实验视频
Updated: Jun 4, 2025

10:58
Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
10.8K
使用人工智能和统计数据来管理来自胃肠道癌的腹膜转移
Adam Wojtulewski1,2, Aleksandra Sikora3, Sean Dineen4
1Department of Machine Learning, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa FL 33612, United States.
Briefings in functional genomics
|December 30, 2024
概括
人工智能 (AI) 和统计方法可以检测胃肠道癌症中的腹转移 (PM). 人工智能,特别是深度学习,在PM分析和管理方面表现优于传统统计数据.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 计算生物学 计算生物学
背景情况:
- 腹转移 (PM) 是胃肠道 (GI) 癌症的一个重大挑战,影响患者的预后和治疗策略.
- 准确的检测和PM的管理对于改善临床决策和患者的结果至关重要.
- 传统的统计方法在分析与PM相关的复杂数据集方面存在局限性.
研究的目的:
- 调查人工智能 (AI) 和统计方法的应用,以分析和管理胃肠道癌症中的腹转移 (PM).
- 为了比较传统机器学习 (ML) 和深度学习 (DL) 模型与PM检测的传统统计方法的有效性.
- 在PM的背景下,确定影响AI和统计模型预测准确性的因素.
主要方法:
- 使用PubMed和Google Scholar进行了系统的文献审查,预先定义了关键字和搜索标准.
- 包括了结合人工智能 (机器学习和深度学习) 和统计 (生物统计,物流模型) 方法进行PM分析的研究.
- 在选定的研究中分析了绩效指标和影响因素,如样本大小.
主要成果:
- 与传统的统计方法相比,人工智能方法,包括深度学习 (DL) 和机器学习 (ML),在检测和分析腹转移方面表现出优异的性能.
- 深度学习模型始终产生了最精确的结果,而经典的ML模型显示出高预测准确度,性能不同.
- 较大的样本大小被确定为提高AI和统计模型预测准确性的关键因素.
结论:
- 人工智能和统计方法是检测胃肠道癌症中腹转移的有效工具,有助于诊断和预后.
- 将AI整合到临床实践中可以增强PM的分析和管理,从而改善临床决策和患者的治疗结果.
- 建议多中心合作,以标准化数据收集方法,确保人工智能和统计模型开发的一致和可靠的结果.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.0K
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.7K
相关概念视频
Kaplan-Meier Approach
94
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
94
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328